{"nct_id":"NCT04224272","title":"A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2020-06-10","start_date_type":"ACTUAL","primary_completion_date":"2023-04-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JAZZ"]}